Supernus Pharmaceuticals (S49.F) Q1 2025 Earnings

25FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
0
0.36
0.72
1.07

Details

Expected EPS
0.49426000000000003
Actual EPS
0.7094560515
Surprise EPS
0.22
Surprise Percent
+43.54%

Description

Supernus Pharmaceuticals (S49.F) has reported earnings of 0.7094560515 per share for Q1 2025.

0 Comments

Share your thoughts